The minister of health says the ministry is moving forward in 2024 to unlock Nigeria’s healthcare value chains, inspired by H.E. President Bola Ahmed Tinubu, GCFR.
Domestic manufacturing of in-vitro diagnostics (IVDs), generic pharmaceuticals, vaccines, biologics, and medical devices is critical to advancing health and wellbeing of all Nigerians.
Part of Mr President’s aim in approving the “Unlocking Healthcare Value-Chain’ Initiative”, as part of Nigeria’s Health Sector Renewal Programme, is to optimize end-to-end R&D pathways for addressing priority diseases in Nigeria.
He further stated that the ministry is glad to receive 𝐌𝐫 𝐒𝐚𝐦𝐢𝐫 𝐌𝐚𝐜𝐡𝐨𝐮𝐫, the Chairman & Chief Executive Officer of the 𝐁𝐢𝐨 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭𝐬 𝐆𝐫𝐨𝐮𝐩, and discuss collaborative efforts to deliver on the Presidential directives, through rapidly stimulating local production of in vitro diagnostics and biologics in Nigeria.
He Thanked 𝐁𝐢𝐨 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐆𝐫𝐨𝐮𝐩 for the readiness to work with the ministry through NIPRD2, in accelerating Nigeria’s efforts towards self-reliance in the medium to longer term.
He also fully acknowledge the current tough economic and business environment, and he is confident that the dark clouds will abate and Nigeria shall emerge as envisioned in the Renewed Hope Agenda.
